ANTHERA PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, September 23, 2004, a trademark application was filed for ANTHERA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the ANTHERA PHARMACEUTICALS trademark a serial number of 78488496. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 2, 2021. This trademark is owned by Anthera Pharmaceuticals, Inc.. The ANTHERA PHARMACEUTICALS trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Licensing late-stage clinical pharmaceutical products

Developing clinical pharmaceutical products, excluding development of such products in the fields of neuromuscular diseases and central nervous system-related treatments
anthera pharmaceuticals

General Information

Serial Number78488496
Word MarkANTHERA PHARMACEUTICALS
Filing DateThursday, September 23, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 2, 2021
Registration Number3884419
Registration DateTuesday, November 30, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2005

Trademark Statements

Disclaimer with Predetermined Text"Pharmaceuticals"
Goods and ServicesLicensing late-stage clinical pharmaceutical products
Goods and ServicesDeveloping clinical pharmaceutical products, excluding development of such products in the fields of neuromuscular diseases and central nervous system-related treatments

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 2, 2021
Primary Code035
First Use Anywhere DateThursday, September 9, 2004
First Use In Commerce DateThursday, September 9, 2004
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 2, 2021
Primary Code042
First Use Anywhere DateThursday, September 9, 2004
First Use In Commerce DateThursday, September 9, 2004

Trademark Owner History

Party NameAnthera Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHayward, CA 94545
Party NameAnthera Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94566
Party NameAnthera Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94566

Trademark Events

Event DateEvent Description
Friday, July 2, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, November 30, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, February 23, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 23, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, February 23, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 16, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 30, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, October 26, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 25, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, October 25, 2010ASSIGNED TO LIE
Monday, October 11, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 9, 2010STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 24, 2010USE AMENDMENT FILED
Tuesday, August 24, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, August 24, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 24, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 30, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 27, 2010EXTENSION 5 GRANTED
Friday, February 26, 2010EXTENSION 5 FILED
Saturday, March 27, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 26, 2010TEAS EXTENSION RECEIVED
Monday, September 28, 2009EXTENSION 4 GRANTED
Friday, August 28, 2009EXTENSION 4 FILED
Monday, September 28, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 11, 2009EXTENSION RECEIVED WITH TEAS PETITION
Friday, September 11, 2009PETITION TO REVIVE-GRANTED
Friday, September 11, 2009TEAS PETITION TO REVIVE RECEIVED
Friday, February 27, 2009EXTENSION 3 GRANTED
Friday, February 27, 2009EXTENSION 3 FILED
Friday, February 27, 2009TEAS EXTENSION RECEIVED
Thursday, August 28, 2008EXTENSION 2 GRANTED
Thursday, August 28, 2008EXTENSION 2 FILED
Thursday, August 28, 2008TEAS EXTENSION RECEIVED
Thursday, February 28, 2008EXTENSION 1 GRANTED
Thursday, February 28, 2008EXTENSION 1 FILED
Thursday, February 28, 2008TEAS EXTENSION RECEIVED
Tuesday, March 13, 2007PAPER RECEIVED
Tuesday, August 28, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 14, 2007OPPOSITION TERMINATED NO. 999999
Thursday, June 14, 2007OPPOSITION DISMISSED NO. 999999
Tuesday, April 18, 2006OPPOSITION INSTITUTED NO. 999999
Wednesday, November 9, 2005EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 11, 2005PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2005NOTICE OF PUBLICATION
Thursday, June 30, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 30, 2005ASSIGNED TO LIE
Friday, June 17, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 17, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 2, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 2, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 26, 2005NON-FINAL ACTION MAILED
Monday, April 25, 2005NON-FINAL ACTION WRITTEN
Monday, April 25, 2005ASSIGNED TO EXAMINER
Thursday, September 30, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals anthera products clinical pharmaceutical central diseases nervous system neuromuscular treatments related